XML 74 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Recognition (Tables)
 9 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following is a summary of our net sales by category (in millions):
Three Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
CSCA(1)
Nutrition$127.1 $129.7 $303.8 $436.3 
Upper Respiratory120.9 131.2 370.0 422.2 
Digestive Health113.5 118.1 361.7 368.2 
Pain and Sleep-Aids87.7 94.5 251.9 294.6 
Healthy Lifestyle80.9 79.4 221.3 219.3 
Oral Care66.9 76.7 204.8 235.5 
Skin Care51.9 58.2 158.6 189.8 
Women's Health18.0 10.5 62.0 35.6 
Vitamins, Minerals, and Supplements ("VMS")3.5 4.4 13.0 13.9 
Other CSCA0.9 0.8 2.4 2.5 
Total CSCA$671.3 $703.5 $1,949.5 $2,217.9 
CSCI
Skin Care$91.0 $86.7 $333.5 $293.1 
Upper Respiratory86.1 78.2 206.0 227.9 
Pain and Sleep-Aids56.9 61.1 158.6 163.8 
Healthy Lifestyle53.2 52.4 175.2 179.4 
VMS43.0 46.1 127.4 135.4 
Women's Health32.2 28.5 101.2 89.5 
Oral Care23.3 24.8 75.0 75.5 
Digestive Health9.0 10.8 27.0 30.0 
Other CSCI(2)
21.6 31.7 81.5 86.1 
Total CSCI416.3 420.3 1,285.5 1,280.7 
Total net sales$1,087.5 $1,123.8 $3,235.1 $3,498.7 

(1) We updated our global reporting product categories as a result of legacy sales being moved out of Other CSCA and into respective categories. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.
(2) Consists primarily of the Rare Diseases Business and other miscellaneous or otherwise uncategorized product lines and other adjustments, none of which is greater than 10% of the segment net sales.
We generated net sales in the following geographic locations(1) (in millions):
Three Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
U.S.$656.9 $690.3 $1,917.1 $2,176.3 
Europe(2)
397.3 399.8 1,225.5 1,232.6 
All other countries(3)
33.3 33.7 92.5 89.8 
Total net sales$1,087.5 $1,123.8 $3,235.1 $3,498.7 
(1) The net sales by geography are derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $11.1 million and $26.8 million for the three and nine months ended September 28, 2024, and $11.9 million and $31.0 million for the three and nine months ended September 30, 2023.
(3) Includes net sales generated primarily in Australia and Canada.
Schedule of Contract with Customer Balances
The following table provides information about contract assets from contracts with customers (in millions):
Balance Sheet LocationSeptember 28, 2024December 31, 2023
Short-term contract assetsPrepaid expenses and other current assets$27.4 $28.5